Overview
Hyeon Chu practices practicing medicine in Cheonan, Republic of Korea.
Chu is highly rated in 3 conditions, according to our data. Their clinical expertise encompasses Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease), Primary Lateral Sclerosis, COVID-19, and Gastrostomy.
They are actively involved in clinical research, co-authoring 23 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Hyeon S. Chu
Is Hyeon S. Chu a top-rated expert for Gastrostomy?
MediFind is an objective health platform that identifies experts based on real-world data. Hyeon S. Chu is classified as an Distinguished expert for Gastrostomy, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Hyeon S. Chu participate in research or clinical trials?
Yes. Hyeon S. Chu has published 23 articles and abstracts on conditions like Gastrostomy. You can view a list of Hyeon S. Chu's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- GastrostomyChu isDistinguished. Learn about Gastrostomy.
- Advanced
- Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease)
- Primary Lateral Sclerosis
- Experienced
- COVID-19Chu isExperienced. Learn about COVID-19.